Senior Consultant Real World Evidence - Focus on Healthcare Data Analysis

About the role

The Senior Consultant will design, execute, and interpret analyses based on claims and registry data to generate real-world evidence for pharmaceutical and medical device clients. This role involves providing strategic consulting for market access and HE&OR departments, ensuring technical quality in interdisciplinary projects, and mentoring team members. The position requires translating complex data findings into strategic recommendations and scientific publications.

Responsibilities

• Design, execute, and interpret analyses based on claims and registry data
• Contextualize analysis results to generate real-world evidence and strategic recommendations
• Provide strategic consulting for market access, HE&OR, and RWE departments
• Provide technical oversight and quality assurance for interdisciplinary projects
• Mentor less experienced colleagues
• Support HTA-related issues and translate results into reports and publications
• Conduct systematic literature reviews and structured evaluations
• Contribute to the development of internal data and methodological expertise

Required skills

• Claims data analysis
• Health insurance fund data
• Registry data
• Epidemiological methods
• Statistical methods
• Scientific writing
• German
• English

Nice to have

• R
• Python
• HTA
• Market access

Qualifications

• Master's degree or diploma in health services research, public health, health economics, statistics, epidemiology or a comparable field
• Several years of relevant professional experience in claims data analysis

Benefits

• Professional development
• Individual training
• Flexible working hours
• 30 days of holiday
• Additional time off on Christmas Eve and New Year's Eve

About the Company

IGES GmbH specialises in health economic and strategic research and consulting services for international pharmaceutical and medical device manufacturers. The company is part of the Athagoras Group and provides support for market access, pricing, and reimbursement of medical innovations.